The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agents
Rajshekhar Chakraborty(Columbia University Irving Medical Center), Morie A. Gertz(Medical University of South Carolina), Francis K. Buadi, Nelson Leung(WinnMed), Shaji Kumar(Mayo Clinic), Prashant Kapoor, Eli Muchtar(Mayo Clinic), William J. Hogan(Mayo Clinic), M. Q. Lacy(Mayo Clinic in Arizona), Angela Dispenzieri(Mayo Clinic), S. R. Hayman(Mayo Clinic), David Dingli
Cited by 33
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k